Market Overview

Myomo® to Present at Noble Capital Markets' 15th Annual Investor Conference


Myomo, Inc. (NYSE:MYO) ("Myomo," or the "Company"), a wearable
medical robotics company, today announced that it will be presenting at
NobleCon15 - Noble Capital Markets' Fifteenth Annual Investor Conference
at the W Hotel, Fort Lauderdale, Florida on Monday, January 28th at
10:30 AM EST - Studio 3. Chairman and Chief Executive Officer Paul R.
Gudonis and Chief Financial Officer Ralph A. Goldwasser will be
presenting, as well as meeting with investors.

A high-definition, video webcast of the presentation will be available
the following day on Myomo's Investor
page, and as part of a complete catalog of presentations
available at Noble Capital Markets' Conference website:
and on the new investor portal created by Noble called Channelchek:
The webcast will be archived on Myomo's website, the NobleCon website
and on for 90 days following the event.

About Myomo

Myomo, Inc. is a wearable medical robotics company that offers expanded
mobility for those suffering from neurological disorders and upper limb
paralysis. Myomo develops and markets the MyoPro product line. MyoPro is
a powered upper limb orthosis designed to support the arm and restore
function to the weakened or paralyzed arms of patients suffering from
CVA stroke, brachial plexus injury, traumatic brain or spinal cord
injury, ALS or other neuromuscular disease or injury. It is currently
the only marketed device that, sensing a patient's own EMG signals
through non-invasive sensors on the arm, can restore an individual's
ability to perform activities of daily living, including feeding
themselves, carrying objects and doing household tasks. Many are able to
return to work, live independently and reduce their cost of care. Myomo
is headquartered in Cambridge, Massachusetts, with sales and clinical
professionals across the U.S. and a business development office in
Europe. For more information, please visit

About Noble Capital Markets, Inc.

2019 marks Noble Capital Markets' 35th anniversary. The Company is an
equity-research driven, full-service, investment & merchant banking
boutique focused on emerging growth companies. In addition to NobleCon,
Noble hosts numerous "non-deal" corporate road shows across the United
States and Canada. In late 2018, Noble launched which
features advanced market data, institutional-quality research, balanced
news, videos and podcasts covering more than 6,000 emerging growth
companies. There is no cost for investors to join. Members: FINRA, SIPC,

Forward-Looking Statements

This press release contains forward-looking statements regarding the
Company's future business expectations, including adoption of MyoPro by
adolescent users, which are subject to the safe harbor provisions of the
Private Securities Litigation Reform Act of 1995. These forward-looking
statements are only predictions and may differ materially from actual
results due to a variety of factors. Our actual results could differ
materially from those anticipated in these forward looking statements
for many reasons, including, without limitation, risks related to
regulatory approval and market acceptance of our products, and the other
risk factors contained in our filings made with the Securities and
Exchange Commission. More information about factors that potentially
could affect Myomo's business and financial results is included in
Myomo's filings with the Securities and Exchange Commission. The Company
cautions readers not to place undue reliance on any such forward-looking
statements, which speak only as of the date made. The Company disclaims
any obligation subsequently to revise any forward-looking statements to
reflect events or circumstances after the date of such statements or to
reflect the occurrence of anticipated or unanticipated events.

View Comments and Join the Discussion!